Plasma Cell Leukemia. Case presentation
Abstract
Plasma Cell Leukemia, is a rare and aggressive variant of multiple myeloma characterized by the presence in the blood circulation of plasma cells, it is classified as primary or secondary to a multiple myeloma, it represents from 2 to 4% of all cases of this disease. A female, 68 year old patient is presented with a history of low back pain, thrombocytopenia anemia, hepatosplenomegaly and 25% of plasma cells in the peripheral lamina concluding as a plasma cell leukemia.
Downloads
References
Gluzinski A, Reichentein M. Myeloma und leucaemia lymphatica plasmocellularis. Wien Klin Wochenschr. 1906; 19: 336.
Alcalde Dueñas MM, Rodríguez Matos G, Santos González MR, Escobar Carmona E. Mieloma múltiple en una forma infrecuente de debut y evolución. Presentación de caso. Gac Méd Espirituana [Internet]. 2012 [citado 12 Feb 2014]; 14(2): [aprox. 8 p.]. Disponible en: http://www.revgmespirituana.sld.cu/index.php/gme/article/viewArticle/136
Albarracín F, Fonseca R. Plasma cell leukemia. Blood Rev [Internet]. 2011 [citado 12 Mar 2014]; 25(3):107-10. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907188/pdf/nihms-546032.pdf
García Sanz R, Orfao A, González M, Tabernero MD, Bladé J, Moro MJ, et al. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood. 2009; 93: 1032–1037.
Ramsingh G, Mehan P, Luo J, Vij R, Morgensztern D. Primary plasma cell leukemia: a surveillance, epidemiology, and end results database analysis between 1973 and 2004. Cancer. 2009; 115: 5734–5739.
Pagano L, Valentini CG, De Stefano V, Venditti A, Visani G, Petrucci MT, et al. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol [Internet]. 2011 [citado 12 Mar 2014]; 22(7):1628-1635. Disponible en: http://annonc.oxfordjournals.org/content/22/7/1628.full.pdf+html
International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haemat. 2003; 121: 749–757.
Bladé J, Kyle RA. Nonsecretory myeloma, immunoglobulin D myeloma, and plasma cell leukemia. Hematol Oncol Clin North Am. 2009; 13: 1259–1272.
D'Arena G, Valentini CG, Pietrantuono G, Guariglia R, Martorelli MC, Mansueto A. Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from Multiple Myeloma Working Party. Ann Oncol. 2012; 23: 1499–1503.
De Larrea CF, Kyle RA, Durie BG, Ludwig H, Usmani S, Vesole DH, et al. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia [Internet]. 2013 [citado 12 Mar 2014]; 27(4): 780-791. Disponible en: http://www.nature.com/leu/journal/v27/n4/pdf/leu2012336a.pdf
The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003; 121: 749-57.
